Clinical Trial Update: Japanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHL [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/II trial updates for copanlisib in relapsed, indolent B-cell non-Hodgkin lymphoma conducted in Japan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Copanlisib (copanlisib)

Snippet

Sponsor: Bayer | Conditions: Lymphoma Non-Hodgkin | Phase 1, Phase 2 | Status: COMPLETED